Small Cap Cannabis Stock Beats Wall Street Expectations By 513%

Trulieve Cannabis (TCNNF) is a multi-state cannabis firm that has made big waves in the marijuana market. 

What makes this company enticing is the fact that it’s a small, yet profitable cannabis operator.

In its most recent quarter, the company reported earnings before interest, taxes, depreciation, and amortization (EBITDA) of $90.8 million… Compared to Wall Street’s projected $14.8 million (a 513% surprise).

Meanwhile, the company’s revenue for the quarter was $193.8 million versus the estimated $189.2 million. Trulieve’s gross margin – or the revenue a firm retains after accounting for costs – came in at an impressive 70%.

Much of this can be attributed to TCNNF’s rapid expansion across the U.S.

In May, the firm completed its acquisition of West Virginian marijuana company Mountaineer Holding.

Through the deal, TCNNF obtained the company’s cultivation license and access to two dispensary permits. 

Trulieve recently announced it would acquire Harvest Health, Solevo Wellness, and Keystone Shops as well. 

This suggests that with increased legalization on the state level, the company is well-positioned to benefit from the herb’s growing popularity.

As the U.S. continues to look into possibly legalizing it on a federal level, TCNNF should benefit as well, as it has established its presence in several key markets.

Make THIS your next play…